🔎 Spotted in Journal of Cellular Biochemistry by @wileyonlinelibrary.bsky.social!
Researchers at @uspoficial.bsky.social used our anti-osteopontin [MPIIIB10(1)] mAb in a new study showing that agrin supports bone formation and may be a promising therapeutic target for bone loss–related conditions.